Epidemiology of non-tuberculous mycobacterial (NTM) infections in bronchiectasis patients using the US Bronchiectasis/NTM Research Registry (BRR)
M. Drysdale (London, United Kingdom), R. Choate (Lexington, United States), N. Lininger (Portland, United States), A. Brunton (Portland, United States), H. Sharma (London, United Kingdom), S. Shrimpton (London, United Kingdom), D. Mannino (Lexington, United States), K. Winthrop (Portland, United States), S. Tiberi (London, United Kingdom)
Source: International Congress 2022 – Epidemiological assessments and public health studies on tuberculosis and NTM
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Drysdale (London, United Kingdom), R. Choate (Lexington, United States), N. Lininger (Portland, United States), A. Brunton (Portland, United States), H. Sharma (London, United Kingdom), S. Shrimpton (London, United Kingdom), D. Mannino (Lexington, United States), K. Winthrop (Portland, United States), S. Tiberi (London, United Kingdom). Epidemiology of non-tuberculous mycobacterial (NTM) infections in bronchiectasis patients using the US Bronchiectasis/NTM Research Registry (BRR). 1901
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|